IP Library Granted Patent US 10,864,256
Granted Patent B2
US 10,864,256 · App. 16/751,108 · Granted Dec 15, 2020

Methods and compositions for improved cognition

Inventor: Dena Dubal (Oakland, CA)
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
A61K38/47A61P25/28C12N9/2402C12Y302/01031A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,864,256
App. No.
16/751,108
Granted
Dec 15, 2020
Kind
B2
Abstract

Provided herein are klotho polypeptide compositions and methods for improving cognitive function in an individual comprising treatment of with klotho polypeptides.

Claims (14)

1. A method of treating cognitive decline in an individual having a mental or mood disorder, comprising administering systemically to the individual an effective amount of a recombinant polypeptide comprising an amino acid sequence having at least 95% identity to the sequence of amino acids 34-979 of SEQ ID NO:1, with the proviso that the polypeptide is not a FGF fusion protein.

2. The method of claim 1 , wherein the individual's mental or mood disorder is depression, schizophrenia, attention deficit/hyperactivity disorder, autism spectrum disorder, or intellectual disability.

3. The method of claim 2 , wherein the individual's mental or mood disorder is depression.

4. The method of claim 2 , wherein the individual's mental or mood disorder is schizophrenia.

5. The method of claim 2 , wherein the individual's mental or mood disorder is attention deficit/hyperactivity disorder.

6. The method of claim 2 , wherein the individual's mental or mood disorder is autism spectrum disorder.

7. The method of claim 2 , wherein the individual's mental or mood disorder is intellectual disability.

8. The method of claim 1 , wherein the amino acid sequence is at least 99% identical to amino acids 34-979 of SEQ ID NO:1.

9. The method of claim 1 , wherein the amino acid sequence comprises amino acids 34-979 of SEQ ID NO:1.

10. The method of claim 1 , comprising:

determining cognitive function in the subject before administration of the polypeptide,

determining cognitive function in the subject following systemic administration of the polypeptide, and

comparing the cognitive function in the subject before administration of the klotho to the cognitive function of the subject following administration of the polypeptide.

11. The method of claim 1 , wherein the polypeptide is administered to the subject intravenously.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2020
From: DUBAL, DENA
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 053580/0573 →
Continuity (3)
Continuation 15548306
Provisional Application 62113300 · Feb 6, 2015
Related Publication 20200230214A1 · Jul 23, 2020
Cited By (1)
US 12,239,694